Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
FASEB J ; 21(9): 2101-7, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17341682

ABSTRACT

The known functions of folate are to support one-carbon metabolism and to serve as photoreceptors for cryptochromes and photolyases. We demonstrate that 5-methyltetrahydrofolate (5-MTHF, the predominant folate in plasma) is also a potent, near diffusion limited, scavenger of singlet oxygen and quencher of excited photosensitizers. Both pathways result in decomposition of 5-MTHF, although ascorbate can protect against this loss. In the absence of photosensitizers, 5-MTHF is directly decomposed only very slowly by UVA or UVB. Although synthetic folic acid can promote DNA damage by UVA, submicromolar 5-MTHF inhibits photosensitization-induced strand breaks. These observations suggest a new role for reduced folate in protection from ultraviolet damage and have bearing on the hypothesis that folate photodegradation influenced the evolution of human skin color.


Subject(s)
DNA Breaks , DNA Damage/drug effects , Folic Acid/physiology , Free Radical Scavengers/pharmacology , Photosensitizing Agents/antagonists & inhibitors , Tetrahydrofolates/pharmacology , Ascorbic Acid/pharmacology , Chromatography, High Pressure Liquid , DNA, Superhelical/drug effects , DNA, Superhelical/radiation effects , Depression, Chemical , Folic Acid/chemical synthesis , Folic Acid/pharmacology , Oxidation-Reduction , Pentetic Acid/pharmacology , Photochemistry , Photosensitizing Agents/pharmacology , Pteridines/antagonists & inhibitors , Pteridines/pharmacology , Rose Bengal/pharmacology , Rose Bengal/radiation effects , Singlet Oxygen/metabolism , Sodium Azide/pharmacology , Superoxide Dismutase/metabolism , Ultraviolet Rays/adverse effects
2.
Cancer Chemother Pharmacol ; 23(5): 283-90, 1989.
Article in English | MEDLINE | ID: mdl-2706732

ABSTRACT

The transport routes used by CCRF-CEM human lymphoblastoid cells for the influx and efflux of unconjugated pteridines were analyzed using [3H]6-hydroxymethylpterin as a model compound. Influx proceeds by a mechanism that exhibits a Km of 66.7 microM and a Vmax of 0.077 nmol/min per mg cellular protein. The process is somewhat sensitive to metabolic inhibitors, particularly uncouplers of oxidative phosphorylation, and is significantly affected by the presence of other pteridines in the extracellular medium. The results suggest that pterins with either no 6-substituent (pterin) or those with methyl, hydroxyl, or formyl groups in this position, which exhibit Ki values between 25 and 77 microM, may share the same pathway for uptake. 6-Carboxypterin exhibits low affinity for the system (Ki greater than 500 microM), as do 7-substituted and 6,7-di-substituted derivatives and compounds with larger groups at the 6-position, such as neopterin and biopterin (Ki = 250-300 microM). Efflux of [3H]6-hydroxymethylpterin occurs rapidly and can proceed by at least two routes. The first, comprising approximately 50% of total efflux, is inhibited by extracellular pterins and exhibits similar properties to the uptake system in both its pattern of sensitivity to metabolic inhibitors and its specificity for pteridine structure. The route by which the remaining efflux occurs is relatively insensitive to metabolic inhibition. Adenine significantly inhibits 6-hydroxymethylpterin influx and efflux (Ki = 10.6 microM for uptake) but does not appear to share the same transport system. Similarly, methotrexate and folic acid exhibit little affinity for the unconjugated pteridine transport routes.


Subject(s)
Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Pteridines/pharmacokinetics , Biological Transport , Carbon Radioisotopes , Cell Line , Chromatography, Gel , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Humans , Pteridines/analysis , Pteridines/antagonists & inhibitors , Pteridines/pharmacology , Pterins/analysis , Pterins/antagonists & inhibitors , Pterins/pharmacokinetics , Tritium , Tumor Cells, Cultured
9.
Science ; 158(3803): 922-4, 1967 Nov 17.
Article in English | MEDLINE | ID: mdl-6054162

ABSTRACT

A known inhibitor of pteridine utilization (4-phenoxy,2,6-diamino pyridine) blocks the synthesis of colored carotenoids in the photosynthetic bacterium Rhodospirillum rubrum. In many ways the effect is similar to the inhibition of the synthesis of colored carotenoids by diphenylamine. This inhibition is probably independent of other effects of pteridine on photosynthetic electron transport since it is not as readily reversible as the total inhibition of photosynthetic activity by pteridine analogs.


Subject(s)
Carotenoids/biosynthesis , Photosynthesis/drug effects , Pteridines/antagonists & inhibitors , Rhodospirillum/metabolism , Darkness , Electron Transport/drug effects , Pyridines/pharmacology , Spectrum Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...